Gastroenterology & Hepatology

Department of Medicine Researchers Publish Groundbreaking Study on Gut Fungi's Lasting Impact on Severe COVID-19 Immune Response

A new study lead by Weill Department of Medicine and NewYork-Presbyterian investigators finds that certain gut-dwelling fungi flourish in severe cases of COVID-19, amplifying the excessive inflammation that drives the disease while also causing long-term immune system changes. This discovery also identifies a group of patients who may benefit from specialized, but yet-to-be determined treatments.The research reveals a new dimension of the...

NIH Awards Dr. Greg Sonnenberg Key Grant to Help Identify Underlying Causes of IBD

sonnenberg lab
Dr. Gregory F. Sonnenberg, The Henry R. Erle, M.D.-Roberts Family Associate Professor of Medicine and head of basic research in the division of Gastroenterology and Hepatology in the Weill Department of Medicine, has been awarded a $3.26 million, five-year MERIT grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to investigate the underlying causes of inflammatory bowel disease (IBD).The new grant, which has the...

Shentique Brown, RN, Among Recipients of Weill Cornell Medicine's First Annual Nursing Awards


Coinciding with National Nurses Week, Shentique Brown, RN, was among the recipients of Weill Cornell Medicine’s first annual nursing awards. Shentique, a nurse in the division of Gastroenterology & Hepatology, received the first annual Rising Star Nursing Award at a ceremony May 11 in the Belfer Research Building.“It’s...

Dr. Brandman Appointed as Medical Director for the Center for Liver Disease and Transplantation

Dr. Danielle Brandman
Dr. Brandman aims to expand the existing care models for liver transplant patients with alcohol related liver disease and nonalcoholic fatty liver disease, as well as to improve outreach efforts to patients with advanced liver disease.

Group 2 Innate Lymphoid Cells (ILC2s) Essential in Protecting Barrier Tissues from Parasitic Infections

Dr. David Artis
Dr. Artis and team continue to illuminate the role of ILC2s, a family of white blood cells, with a new discovery published in Nature that has resolved an ongoing controversy.

Dr. Artis and Colleagues Discover Pain-Sensing Gut Neurons that Protect Against Inflammation

Dr. David Artis
As reported in Cell, these pain-sensing neurons protect against inflammation in the gut as well as the associated tissue damage, apparently by secreting a molecule called substance P.

Dr. Iliev Publishes Key Finding on Fungal Species in Tumors in Cell

Dr. Iliyan Iliev
The breakthrough research holds promise for developing diagnostic tests for the prediction of cancer progression and therapy.

Dr. Sonnenberg and Colleagues Publish Key Finding in Nature: How Immune System Tolerates Friendly Gut Bacteria

Dr. Gregory Sonnenberg
Building upon his laboratory’s many discoveries centered around ILC3s, Dr. Gregory Sonnenberg has published another breakthrough in Nature (September 7, 2022).

Dr. Iliev Receives Lloyd J. Old Star Program Grant: Role of Fungi in Cancer Development and Immunotherapy

Dr. Iliyan Iliev
This five-year, $1.25 million grant will enable Dr. Iliev to continue his innovative research into the relationship between certain types of fungi and specific cancers.

Dr. Blander Receives Outstanding Scientific Achievements Award from the European Macrophage and Dendritic Cell Society

Dr. Julie Blander
This award recognizes exceptional researchers whose scientific excellence and pioneering work have significantly advanced scientific development for the benefit of humanity.

Gastroenterology and Hepatology

Robert S. Brown, Jr., M.D., M.P.H., Chief

Andrew Crawford, Administrator
Tel: (646) 962-5629




Clinical Trials

Patient Care Resources

Gastroenterology and Hepatology